Nanjing NeuroDawn Pharmaceutical Co., Ltd.
PrivateLast Round
Series C
Nov 1, 2024
Total Funding Raised
$53.48M
Company Overview
Nanjing NeuroDawn Pharmaceutical Co., Ltd. is a biotechnology company that focuses on the research and development of innovative drugs for central nervous system (CNS) diseases, including stroke, cognitive impairment, and neuropathic pain.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials
Business Model
B2B
Customer Profile
Services & Consulting, Data as a Service
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Nanjing NeuroDawn Pharmaceutical Co., Ltd. Comparables
Compare Nanjing NeuroDawn Pharmaceutical Co., Ltd. with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Fosun Pharma | 77% | |
| NoNO Inc. | 77% | |
| Avilex Pharma | 77% |
Nanjing NeuroDawn Pharmaceutical Co., Ltd. Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Nov 1, 2024 | ||||
| Series B | Jan 12, 2024 | ||||
| Series A Extension | Feb 9, 2023 | ||||
| Series A | Aug 23, 2021 |
Nanjing NeuroDawn Pharmaceutical Co., Ltd. Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Tencent Exploration | Series B |
| 盛世投资 (Shengshi Investment) | Series C |
| CITIC Construction Investment Capital Management | Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 1, 2024
$28M round led by Shengshi Investment.
- Jan 12, 2024
$28M round with Tencent Exploration and CITIC Construction.
Nanjing NeuroDawn Pharmaceutical Co., Ltd. Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Nanjing NeuroDawn Pharmaceutical Co., Ltd.'s valuation, stock price, and market status.
Is Nanjing NeuroDawn Pharmaceutical Co., Ltd. a public or private company?
Nanjing NeuroDawn Pharmaceutical Co., Ltd. is a private company.
What is the current stock price of Nanjing NeuroDawn Pharmaceutical Co., Ltd.?
Nanjing NeuroDawn Pharmaceutical Co., Ltd. is a private company, so its shares have no public market price. Caplight tracks Nanjing NeuroDawn Pharmaceutical Co., Ltd.'s secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Nanjing NeuroDawn Pharmaceutical Co., Ltd. worth (valuation)?
Valuation information for Nanjing NeuroDawn Pharmaceutical Co., Ltd. is not publicly available.
Can I buy Nanjing NeuroDawn Pharmaceutical Co., Ltd. stock?
Nanjing NeuroDawn Pharmaceutical Co., Ltd. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Nanjing NeuroDawn Pharmaceutical Co., Ltd.'s last funding round?
Nanjing NeuroDawn Pharmaceutical Co., Ltd.'s most recent funding round was Series C on November 1, 2024.
Who are the main investors in Nanjing NeuroDawn Pharmaceutical Co., Ltd.?
Key investors in Nanjing NeuroDawn Pharmaceutical Co., Ltd. include Tencent Exploration, 盛世投资 (Shengshi Investment), CITIC Construction Investment Capital Management.
Will Nanjing NeuroDawn Pharmaceutical Co., Ltd. IPO soon?
No public IPO plans have been announced for Nanjing NeuroDawn Pharmaceutical Co., Ltd..
How can I track Nanjing NeuroDawn Pharmaceutical Co., Ltd. secondary market activity?
Caplight tracks bids, offers, and trades in Nanjing NeuroDawn Pharmaceutical Co., Ltd.'s shares on secondary markets.